Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Oct 25, 2021

BUY
$372.64 - $458.3 $3,726 - $4,583
10 Added 12.5%
90 $37,000
Q2 2021

Jul 26, 2021

BUY
$294.17 - $371.65 $8,825 - $11,149
30 Added 60.0%
80 $30,000
Q4 2020

Jan 22, 2021

BUY
$222.0 - $252.62 $5,550 - $6,315
25 Added 100.0%
50 $12,000
Q3 2020

Oct 13, 2020

BUY
$175.56 - $226.45 $4,389 - $5,661
25 New
25 $6,000

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $10.1B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Centerpoint Advisors, LLC Portfolio

Follow Centerpoint Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Centerpoint Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Centerpoint Advisors, LLC with notifications on news.